Clinical Trial Update: A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating Teverelix DP, a GnRH antagonist, for pharmacokinetics, pharmacodynamics, efficacy and safety in advanced prostate cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Teverelix DP (teverelix)

Snippet

Sponsor: Antev Ltd. | Conditions: Advanced Prostate Cancer, GnRH Antagonist | Phase 2 | Status: NOT_YET_RECRUITING